Načítá se...
Emerging biomarkers for the combination of radiotherapy and immune checkpoint blockers
Over the past few years, multiple immune checkpoint blockers (ICBs) have achieved unprecedented clinical success and have been approved by regulatory agencies for the treatment of an increasing number of malignancies. However, only a limited fraction of patients responds to ICBs employed as a standa...
Uloženo v:
| Vydáno v: | Semin Cancer Biol |
|---|---|
| Hlavní autoři: | , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6004231/ https://ncbi.nlm.nih.gov/pubmed/29258856 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.semcancer.2017.12.007 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|